Literature DB >> 11274480

Solubilization and disaggregation of polyglutamine peptides.

S Chen1, R Wetzel.   

Abstract

A method is described for dissolving and disaggregating chemically synthesized polyglutamine peptides. Polyglutamine peptides longer than about Q20 have been reported to be insoluble in water, but dissolution in--and evaporation from--a mixture of trifluoroacetic acid and hexafluoroisopropanol converts polyglutamine peptides up to at least Q44 to a form readily soluble in aqueous buffers. This procedure also has a dramatic effect on peptides which appear to be completely soluble in water, by removing traces of aggregate that seed aggregation. The protocol makes possible solution studies-including in vitro aggregation experiments--on polyglutamine peptides with repeat lengths associated with increased risk of Huntington's Disease and other expanded CAG repeat diseases. It may also be useful in conducting reproducible, quantitative aggregation studies on other polypeptides.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274480      PMCID: PMC2373971          DOI: 10.1110/ps.42301

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  14 in total

1.  Inhibition of aggregation side reactions during in vitro protein folding.

Authors:  E De Bernardez Clark; E Schwarz; R Rudolph
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

Review 2.  Amyloidosis.

Authors:  J D Sipe
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

Review 3.  Mad cows meet psi-chotic yeast: the expansion of the prion hypothesis.

Authors:  S Lindquist
Journal:  Cell       Date:  1997-05-16       Impact factor: 41.582

4.  Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology.

Authors:  E Scherzinger; A Sittler; K Schweiger; V Heiser; R Lurz; R Hasenbank; G P Bates; H Lehrach; E E Wanker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

5.  Infrared and laser-Raman spectroscopic studies of thermally-induced globular protein gels.

Authors:  A H Clark; D H Saunderson; A Suggett
Journal:  Int J Pept Protein Res       Date:  1981-03

Review 6.  Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins.

Authors:  J D Harper; P T Lansbury
Journal:  Annu Rev Biochem       Date:  1997       Impact factor: 23.643

7.  Perfluorinated acid alternatives to trifluoroacetic acid for reversed-phase high-performance liquid chromatography.

Authors:  J D Pearson; M C McCroskey
Journal:  J Chromatogr A       Date:  1996-10-11       Impact factor: 4.759

Review 8.  Fourteen and counting: unraveling trinucleotide repeat diseases.

Authors:  C J Cummings; H Y Zoghbi
Journal:  Hum Mol Genet       Date:  2000-04-12       Impact factor: 6.150

9.  Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases.

Authors:  M F Perutz; T Johnson; M Suzuki; J T Finch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

10.  Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E.

Authors:  S J Wood; W Chan; R Wetzel
Journal:  Biochemistry       Date:  1996-09-24       Impact factor: 3.162

View more
  60 in total

1.  Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate dehydrogenase and polyglutamine repeats.

Authors:  Margherita Ruoppolo; Stefania Orrù; Simona Francese; Ivana Caputo; Carla Esposito
Journal:  Protein Sci       Date:  2003-01       Impact factor: 6.725

2.  A structural model of polyglutamine determined from a host-guest method combining experiments and landscape theory.

Authors:  John M Finke; Margaret S Cheung; José N Onuchic
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

Review 3.  Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence.

Authors:  Ronald Wetzel
Journal:  J Mol Biol       Date:  2012-01-27       Impact factor: 5.469

4.  Side-chain interactions determine amyloid formation by model polyglutamine peptides in molecular dynamics simulations.

Authors:  Alexander J Marchut; Carol K Hall
Journal:  Biophys J       Date:  2006-03-24       Impact factor: 4.033

5.  In vitro polymerization of a functional Escherichia coli amyloid protein.

Authors:  Xuan Wang; Daniel R Smith; Jonathan W Jones; Matthew R Chapman
Journal:  J Biol Chem       Date:  2006-12-12       Impact factor: 5.157

6.  The aggregation kinetics of Alzheimer's beta-amyloid peptide is controlled by stochastic nucleation.

Authors:  Peter Hortschansky; Volker Schroeckh; Tony Christopeit; Giorgia Zandomeneghi; Marcus Fändrich
Journal:  Protein Sci       Date:  2005-06-03       Impact factor: 6.725

7.  Structural motif of polyglutamine amyloid fibrils discerned with mixed-isotope infrared spectroscopy.

Authors:  Lauren E Buchanan; Joshua K Carr; Aaron M Fluitt; Andrew J Hoganson; Sean D Moran; Juan J de Pablo; James L Skinner; Martin T Zanni
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

8.  Fluorescence correlation spectroscopy shows that monomeric polyglutamine molecules form collapsed structures in aqueous solutions.

Authors:  Scott L Crick; Murali Jayaraman; Carl Frieden; Ronald Wetzel; Rohit V Pappu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

Review 9.  A novel therapeutic strategy for polyglutamine diseases by stabilizing aggregation-prone proteins with small molecules.

Authors:  Motomasa Tanaka; Yoko Machida; Nobuyuki Nukina
Journal:  J Mol Med (Berl)       Date:  2005-03-10       Impact factor: 4.599

10.  Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions.

Authors:  Elizabeth J Slow; Rona K Graham; Alexander P Osmand; Rebecca S Devon; Ge Lu; Yu Deng; Jacqui Pearson; Kuljeet Vaid; Nagat Bissada; Ronald Wetzel; Blair R Leavitt; Michael R Hayden
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.